Gemma G. Kenter

21.1k total citations · 4 hit papers
234 papers, 14.4k citations indexed

About

Gemma G. Kenter is a scholar working on Epidemiology, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Gemma G. Kenter has authored 234 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Epidemiology, 79 papers in Obstetrics and Gynecology and 70 papers in Oncology. Recurrent topics in Gemma G. Kenter's work include Cervical Cancer and HPV Research (96 papers), Endometrial and Cervical Cancer Treatments (79 papers) and Immunotherapy and Immune Responses (50 papers). Gemma G. Kenter is often cited by papers focused on Cervical Cancer and HPV Research (96 papers), Endometrial and Cervical Cancer Treatments (79 papers) and Immunotherapy and Immune Responses (50 papers). Gemma G. Kenter collaborates with scholars based in Netherlands, United States and United Kingdom. Gemma G. Kenter's co-authors include Gert Jan Fleuren, Sjoerd H. van der Burg, Cornelis J.M. Melief, Ekaterina S. Jordanova, Rienk Offringa, Marij J.P. Welters, Jan W. Drijfhout, Katja N. Gaarenstroom, J. Baptist Trimbos and Jeanette M. van der Hulst and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Gemma G. Kenter

229 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

2010 1.7k citations Ignace Vergote, Gunnar B. Kristensen et al. profile →
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. profile →
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

2011 387 citations Gemma G. Kenter et al. profile →
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

2018 373 citations Henry Zijlmans, Gemma G. Kenter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gemma G. Kenter Netherlands	64	5.2k	5.0k	4.5k	3.6k	3.6k	234	14.4k
Ronald D. Alvarez United States	63	4.3k 0.8×	1.6k 0.3×	2.0k 0.4×	1.7k 0.5×	2.7k 0.7×	340	12.5k
Gert Jan Fleuren Netherlands	61	4.8k 0.9×	5.8k 1.2×	3.1k 0.7×	1.6k 0.4×	934 0.3×	234	12.6k
Leon F.A.G. Massuger Netherlands	59	2.8k 0.5×	1.1k 0.2×	3.8k 0.8×	3.5k 1.0×	2.5k 0.7×	360	12.8k
Sërgio Pecorelli Italy	50	2.9k 0.6×	1.5k 0.3×	1.6k 0.4×	2.1k 0.6×	3.9k 1.1×	178	10.6k
Hans W. Nijman Netherlands	52	4.8k 0.9×	5.6k 1.1×	1.3k 0.3×	920 0.3×	3.0k 0.8×	204	13.4k
Peter Kenemans Netherlands	56	2.4k 0.5×	2.2k 0.4×	2.4k 0.5×	1.7k 0.5×	1.5k 0.4×	304	11.6k
René H.M. Verheijen Netherlands	49	2.0k 0.4×	942 0.2×	3.6k 0.8×	3.1k 0.9×	3.1k 0.9×	187	10.2k
Peter E. Schwartz United States	53	3.4k 0.6×	1.3k 0.3×	1.4k 0.3×	1.3k 0.4×	2.1k 0.6×	258	10.3k
R. J. Kurman United States	39	2.1k 0.4×	1.1k 0.2×	5.5k 1.2×	2.6k 0.7×	2.1k 0.6×	62	9.8k
Alex Ferenczy Canada	56	1.8k 0.4×	1.5k 0.3×	6.8k 1.5×	3.6k 1.0×	3.0k 0.8×	280	12.0k

Countries citing papers authored by Gemma G. Kenter

Since Specialization

Citations

This map shows the geographic impact of Gemma G. Kenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma G. Kenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma G. Kenter more than expected).

Fields of papers citing papers by Gemma G. Kenter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma G. Kenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma G. Kenter. The network helps show where Gemma G. Kenter may publish in the future.

Co-authorship network of co-authors of Gemma G. Kenter

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma G. Kenter. A scholar is included among the top collaborators of Gemma G. Kenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma G. Kenter. Gemma G. Kenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lonkhuijzen, Luc R.C.W. van, Gemma G. Kenter, Willemien J. van Driel, et al.. (2024). Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial. British Journal of Cancer. 131(1). 101–109. 5 indexed citations

Hartman, Yvonne, Pedro López, Gemma G. Kenter, et al.. (2022). Association between Energy Balance-Related Factors and Clinical Outcomes in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis. Cancers. 14(19). 4567–4567. 6 indexed citations

Bakker, Noor A. M., Jossie Rotman, Marc van Beurden, et al.. (2021). HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial. Journal for ImmunoTherapy of Cancer. 9(8). e002547–e002547. 12 indexed citations

Griffin, Heather, Maaike C.G. Bleeker, Renske D.M. Steenbergen, et al.. (2021). Delta-Like Ligand–Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis. Cancer Research. 81(7). 1909–1921. 22 indexed citations

Rotman, Jossie, A. Marijne Heeren, Sinéad M. Lougheed, et al.. (2020). Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma. Clinical Cancer Research. 26(14). 3791–3802. 21 indexed citations

Hoedjes, Meeke, et al.. (2020). Rationale and study protocol of the Physical Activity and Dietary intervention in women with OVArian cancer (PADOVA) study: a randomised controlled trial to evaluate effectiveness of a tailored exercise and dietary intervention on body composition, physical function and fatigue in women with ovarian cancer undergoing chemotherapy. BMJ Open. 10(11). e036854–e036854. 24 indexed citations

Vergote, Ignace, Corneel Coens, Matthew Nankivell, et al.. (2019). Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials. Obstetrical & Gynecological Survey. 74(3). 156–158. 30 indexed citations

Rotman, Jossie, Constantijne H. Mom, Ekaterina S. Jordanova, Tanja D. de Gruijl, & Gemma G. Kenter. (2018). ‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment. BMC Cancer. 18(1). 888–888. 27 indexed citations

Samuels, Sanne, Balázs Bálint, Heiko von der Leyen, et al.. (2016). Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study. British Journal of Cancer. 115(12). 1575–1583. 6 indexed citations

10.

Trommel, Nienke E. van, et al.. (2015). The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 123(11). 1839–1845. 21 indexed citations

11.

Rutten, Marianne J., Hannah S. van Meurs, Toon Van Gorp, et al.. (2015). LAPAROSCOPY TO PREDICT THE RESULT OF PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CANCER (LAPOVCA) : A MULTICENTRE RANDOMISED CONTROLLED TRIAL. International Journal of Gynecological Cancer. 25(9). 102–103. 1 indexed citations

12.

Santegoets, Saskia J., A.K.L. Reyners, Renske Goedemans, et al.. (2015). A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer. Annals of Oncology. 26(10). 2141–2149. 163 indexed citations

13.

Heeren, A. Marijne, Bas D. Koster, Sanne Samuels, et al.. (2014). High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer. Cancer Immunology Research. 3(1). 48–58. 95 indexed citations

14.

Meurs, Hannah S. van, Ewoud Schuit, Hugo M. Horlings, et al.. (2014). Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovary. Gynecologic Oncology. 134(3). 498–504. 19 indexed citations

15.

Melker, Hester E. de, et al.. (2012). Ontwikkelingen omtrent de HPV-vaccinatie. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 156(47). 1 indexed citations

16.

Steenwijk, Peggy J. de Vos van, Moniek Heusinkveld, Tamara H. Ramwadhdoebé, et al.. (2010). An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer. Cancer Research. 70(7). 2707–2717. 70 indexed citations

17.

Melief, Cornelis J.M., Marij J.P. Welters, Margriet J. Löwik, et al.. (2008). Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16. 8. 2. 1 indexed citations

18.

Pieterse, Q. D., Cornelis P. Maas, Moniek M. ter Kuile, et al.. (2006). An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. International Journal of Gynecological Cancer. 16(3). 1119–1129. 136 indexed citations

19.

Visser, Marlieke, et al.. (2004). De beroepskeuze van in Leiden afgestudeerde artsen. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 148(47). 1 indexed citations

20.

Gaarenstroom, Katja N., Johannes M.G. Bonfrèr, Gemma G. Kenter, et al.. (1995). Clinical value of pretreatment serum Cyfra 21–1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer. Cancer. 76(5). 807–813. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact